What is RITUXAN?
RITUXAN® (rituximab) is a prescription medicine used to treat adults with:
- Non-Hodgkin’s Lymphoma
(NHL): alone or with other chemotherapy medicines.
- Chronic Lymphocytic Leukemia (CLL): with the chemotherapy medicines fludarabine and cyclophosphamide.
People with serious infections should not receive RITUXAN. It is not known if RITUXAN is safe or effective in children with NHL or CLL.
RITUXAN is not chemotherapy
RITUXAN is a type of antibody therapy that can be used alone or with chemotherapy. They work in different ways to find and attack the cells where cancer starts.
RITUXAN targets and attaches to the CD20 protein found on the surface of blood cells with cancer and some healthy blood cells. Once attached to the CD20 protein, RITUXAN is thought to work in different ways including:
- By helping your own immune system destroy the cancer cells
- By destroying the cancer cells on its own
In addition, RITUXAN can also harm healthy cells in your body.
RITUXAN can be an important part of treatment for many patients with NHL and CLL.
RITUXAN is available by prescription only.